Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2021-10-01 | 2021-09-23 |
| Drug Identification Number | 00872296 | 00872296 |
| Brand name | TRAVASOL | TRAVASOL |
| Common or Proper name | Amino Acids (Blend C) Injection | Amino Acids (Blend C) Injection |
| Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
| Ingredients | LEUCINE SERINE TYROSINE PROLINE ARGININE GLYCINE L-ALANINE TRYPTOPHAN THREONINE HISTIDINE VALINE ISOLEUCINE L-LYSINE METHIONINE PHENYLALANINE | LEUCINE SERINE TYROSINE PROLINE ARGININE GLYCINE L-ALANINE TRYPTOPHAN THREONINE HISTIDINE VALINE ISOLEUCINE L-LYSINE METHIONINE PHENYLALANINE |
| Strength(s) | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1000 mL (JB6584) | 1000 mL (JB6584) |
| ATC code | B05BA | B05BA |
| ATC description | I.V. SOLUTIONS | I.V. SOLUTIONS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | ||
| Actual start date | 2021-09-23 | 2021-09-23 |
| Estimated end date | 2021-10-01 | 2021-10-09 |
| Actual end date | 2021-10-01 | |
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Baxter is experiencing supply constraints due to the shortage of Travasol 10% 3000mL (DIN 00872296). As a result this product has been placed on allocation at 100% of historical usage. | Baxter is experiencing supply constraints due to the shortage of Travasol 10% 3000mL (DIN 00872296). As a result this product has been placed on allocation at 100% of historical usage. |
| Health Canada comments |